Glucoza Infomed Fluids

Glucoza Infomed Fluids is an intravenous solution that contains glucose monohydrate as the active ingredient. The product is supplied in a standard strength (strength not specified) and is manufactured for the European Union market. It is classified as an excipient and is used primarily as a source of carbohydrate in clinical settings. The solution is sterile, isotonic, and intended for administration by healthcare professionals in hospitals, clinics, or emergency care environments.

Glucoza Infomed Fluids is employed in a variety of clinical situations where rapid carbohydrate supplementation is required, particularly in acute care settings.

- Management of hypoglycemia when oral glucose is not feasible. - Provision of caloric support during peri‑operative fasting. - Fluid replacement in patients with dehydration and low blood glucose. - Dilution and carrier for intravenous medications that require a glucose base. - Support for metabolic demands in critically ill or trauma patients.

When administered intravenously, glucose monohydrate solutions can produce a range of physiological responses, most of which are related to changes in blood glucose and fluid balance.

Common: - Transient increase in blood glucose levels. - Mild hyperosmolarity leading to temporary thirst. - Local irritation at the infusion site. - Nausea or mild abdominal discomfort. - Headache or dizziness during infusion.

Serious: - Severe hyperglycemia requiring medical intervention. - Fluid overload causing pulmonary edema. - Electrolyte imbalance, particularly hyponatremia. - Allergic reaction such as rash, itching, or anaphylaxis.

Healthcare providers should observe several precautionary measures before and during the administration of Glucoza Infomed Fluids to ensure patient safety and optimal therapeutic effect.

- Verify patient’s blood glucose level and adjust infusion rate accordingly. - Assess fluid status to avoid volume overload, especially in cardiac or renal impairment. - Use aseptic technique to prevent catheter‑related infections. - Monitor electrolytes, particularly sodium and potassium, during prolonged therapy. - Avoid rapid infusion in neonates or patients with compromised circulation. - Discontinue if signs of allergic reaction or severe hyperglycemia develop.

Glucose monohydrate solutions may interact with other intravenous agents or patient conditions, influencing efficacy or safety.

Avoid: - Co‑administration with high‑dose insulin infusions without close glucose monitoring. - Simultaneous infusion of hypertonic saline solutions that could exacerbate hyperosmolar states. - Use in patients with known severe glucose intolerance or uncontrolled diabetes without specialist oversight.

Use with caution: - Concurrent administration of diuretics, which may alter fluid and electrolyte balance. - Infusion alongside catecholamines, as they can affect glucose metabolism. - Patients receiving total parenteral nutrition, requiring careful monitoring of total carbohydrate load.